Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Use Cases and the Technology Enabling Medical Data, Privacy and Anonymization

Health data makes up more than 30% of the world’s data (Intel, 2022) — and it’s growing each year. The data is more than tangible, straightforward information, like dates of vaccinations and test results. It also includes contextual data, like neighborhood qualities, diet trackers, exercise trackers, sleep monitors, and more. Intel’s principal health engineer,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Health data makes up more than 30% of the world’s data (Intel, 2022) — and it’s growing each year. The data is more than tangible, straightforward information, like dates of vaccinations and test results. It also includes contextual data, like neighborhood qualities, diet trackers, exercise trackers, sleep monitors, and more. Intel’s principal health engineer, Abhishek Khowala, and Agata Chudzinska, head of AI at TheBlue.AI, discuss the necessity of anonymously sharing health data.

With a worldwide shortage of providers, ageing populations, and increasing multi-chronic diseases, sharing, understanding, and learning from health data is more critical than ever. Shared data helps with quicker drug development, more effortless transfer of care, and higher collaboration between research institutes.

“Structured data is what can be presented in a relational database. We pretty much know what fields are related to privacy, and it is a little easier to redact those or remove that from the data. However, the vast majority — over 80% of data — is unstructured; it is tougher to analyze this unstructured data and find out where exactly there is any kind of identifiable information,” says Khowala.

One solution to this issue is natural language processing, an AI feature applied to clinical notes to ensure anonymity. The technology can make sense of the text and remove identifiable information.

Intel and The Blue.AI implemented a mixed-reality solution at a Florida hospital. The solution included multiple sensors and cameras which collected data about patients and staff, they then used Computer vision technology to remove any personally identifiable information.

“In all of these cases, we always need to give humans the possibility to check it,” Chudzinska explains. One example was a photograph of clinicians with their consent after surgery. However, a screen was visible in the background with the name and patient information on it who had undergone surgery. “It’s not always obvious what kind of information can be visible that leads to a specific individual,” Chudzinska continues.

Protecting personal identifiers when sharing health data is just as necessary as sharing the data itself. “What use would the medical data be if it is not shared?” Khowala asks. Ensuring protection is a barrier to data sharing. “Over 70% of the countries worldwide — about 140 countries — already have some kind of regulation that protect the data and privacy of the individuals,” says Chudzinska. AI streamlines the protection process for facilities and makes it possible to remove personal information in minutes and hours instead of days or months with human analysis.

Follow leaders in AI technology, Agata Chudzinska and Abhishek Khowala on LinkedIn. Learn more about Intel’s applied AI health data case studies on the website.

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Health and Life Sciences at the Edge.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits now take 3–5+ years of prep. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512